Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$191.17 - $325.63 $955 - $1,628
5 Added 31.25%
21 $6,000
Q4 2023

Feb 07, 2024

SELL
$160.99 - $215.69 $4,829 - $6,470
-30 Reduced 65.22%
16 $3,000
Q3 2023

Nov 08, 2023

SELL
$194.33 - $283.97 $2,331 - $3,407
-12 Reduced 20.69%
46 $9,000
Q2 2023

Aug 11, 2023

SELL
$223.05 - $302.68 $24,089 - $32,689
-108 Reduced 65.06%
58 $16,000
Q1 2023

May 10, 2023

BUY
$175.41 - $217.92 $5,613 - $6,973
32 Added 23.88%
166 $35,000
Q4 2022

Feb 09, 2023

BUY
$204.38 - $296.82 $2,043 - $2,968
10 Added 8.06%
134 $27,000
Q3 2022

Nov 07, 2022

SELL
$195.21 - $310.53 $5,856 - $9,315
-30 Reduced 19.48%
124 $34,000
Q1 2022

May 10, 2022

BUY
$127.96 - $207.36 $2,943 - $4,769
23 Added 17.56%
154 $32,000
Q4 2021

Jan 21, 2022

BUY
$165.13 - $241.83 $21,632 - $31,679
131 New
131 $23,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.